Reports on a joint venture between Ohio-based private biotechnology company Athersys Inc. and Elan Corp. to develop and commercialize a therapeutic protein for the treatment of AIDS-related muscle wasting. Use of random activation of gene expression technology (RAGE) by Athersys for the large scale production of the therapeutic protein; Benefits of RAGE.